2013•China Medical HeraldRequires access

Effect of Changningfang in treating diarrhea-predominant irritable bowel syndrome

Jin Liao

Open publisher page 0 citations

Abstract

Objective To observe the clinical effect of Changningfang in treating diarrhea-predominant irritable bowel syndrome(D-IBS).Methods 75 patients with D-IBS treated with Changningfang from July 2008 to December 2012 in Guilin TCM Hospital were reviewed.Patients were randomized divided into 38 cases of treatment group and 37 cases of control group.The patients in treatment group were treated with Changningfang,the patients in control group were treated with Pinaverium.Before treatment and after treatment for 3 weeks,the clinical symptoms,symptom scores and the level of 5-hydroxytryptamine serotonin(5-HT),motilin(MOT) in serum were compared.Results The total efficiency and cure rate of syndrome of treatment group(47.4%,92.1%) were better than those of the control group(24.3%,81.1%),there were significant differences between the two groups(P 0.05);the symptom scores of treatment group [(8.52±3.43) points] were better than that of the control group [(13.01±2.50) points],there were significant differences between two groups(P 0.01).The effect of the spleen dampness syndrome type and the stagnation and spleen deficien cy syndrome type in the treatment group(both 100.0%) were better than the control group(77.8%,90.0%),there were significant differences between two groups(P 0.01 or P 0.05);the level of 5-HT,MOT in the treatment group were(433.4±72.6) ng/L,(240.1±11.8) ng/L,which were less than those of control group [(433.4±72.6) ng/L,(314.1±60.7) ng/L],there were significant differences between the two groups(P 0.01).Conclusion Changningfang can significantly improve the D-IBS patients with clinical symptoms,its mechanism of action may be related to the regulation of 5-HT,MOT level.

About this research paper

What this paper is about

Objective To observe the clinical effect of Changningfang in treating diarrhea-predominant irritable bowel syndrome(D-IBS).Methods 75 patients with D-IBS treated with Changningfang from July 2008 to December 2012 in Guilin TCM Hospital were reviewed.Patients were randomized divided into 38 cases of treatment group and 37 cases of control group.The patients in treatment group were treated with Changningfang,the patients in control group were treated with Pinaverium.Before treatment and after treatment for 3 weeks,the clinical symptoms,symptom scores and the level of 5-hydroxytryptamine serotonin(5-HT),motilin(MOT) in serum were compared.Results The total efficiency and cure rate of syndrome of treatment group(47.4%,92.1%) were better than those of the control group(24.3%,81.1%),there were significant differences between the two groups(P 0.05);the symptom scores of treatment group [(8.52±3.43) points] were better than that of the control group [(13.01±2.50) points],there were significant differences between two groups(P 0.01).The effect of the spleen dampness syndrome type and the stagnation and spleen deficien cy syndrome type in the treatment group(both 100.0%) were better than the control group(77.8%,90.0%),there were significant differences between two groups(P 0.01 or P 0.05);the level of 5-HT,MOT in the treatment group were(433.4±72.6) ng/L,(240.1±11.8) ng/L,which were less than those of control group [(433.4±72.6) ng/L,(314.1±60.7) ng/L],there were significant differences between the two groups(P 0.01).Conclusion Changningfang can significantly improve the D-IBS patients with clinical symptoms,its mechanism of action may be related to the regulation of 5-HT,MOT level.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical effect of Changningfang in treating diarrhea-predominant irritable bowel syndrome(D-IBS).Methods 75 patients with D-IBS treated with Changningfang from July 2008 to December 2012 in Guilin TCM Hospital were reviewed.Patients were randomized divided into 38 cases of treatment group and 37 cases of control group.The patients in treatment group were treated with Changningfang,the patients in control group were treated with Pinaverium.Before treatment and after treatment for 3 weeks,the clinical symptoms,symptom scores and the level of 5-hydroxytryptamine serotonin(5-HT),motilin(MOT) in serum were compared.Results The total efficiency and cure rate of syndrome of treatment group(47.4%,92.1%) were better than those of the control group(24.3%,81.1%),there were significant differences between the two groups(P 0.05);the symptom scores of treatment group [(8.52±3.43) points] were better than that of the control group [(13.01±2.50) points],there were significant differences between two groups(P 0.01).The effect of the spleen dampness syndrome type and the stagnation and spleen deficien cy syndrome type in the treatment group(both 100.0%) were better than the control group(77.8%,90.0%),there were significant differences between two groups(P 0.01 or P 0.05);the level of 5-HT,MOT in the treatment group were(433.4±72.6) ng/L,(240.1±11.8) ng/L,which were less than those of control group [(433.4±72.6) ng/L,(314.1±60.7) ng/L],there were significant differences between the two groups(P 0.01).Conclusion Changningfang can significantly improve the D-IBS patients with clinical symptoms,its mechanism of action may be related to the regulation of 5-HT,MOT level.

Key concepts: Medicine, Irritable bowel syndrome, Diarrhea, Internal medicine, Gastroenterology, Motilin, Treatment and control groups

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of Changningfang in treating diarrhea-predominant irritable bowel syndrome — Research Paper | ScholarLens